John Lowe (see references) created a compound anomaly. First, although he is arguably the world's foremost authority on thyroid hormone, he is a chiropractor, among other things, and chiropractors are not supposed to contribute landmark work to the allopathic world. In this, he follows a long tradition that nearly all great discoveries are made by workers who undertook a major shift in scope at a later point in their careers. This is expected that senescent paradigms like allopathic generate all manner of anomalous detritus that allopathics themselves are loathe to investigate; therefore, it is likely to be a non-allopath that picks up the ball and runs with it.

Second, the detritus he picked up and ran with in the first place was an anomaly of the allopathic paradigm generated by the discovery of assays for thyroid hormone, thereby rendering all hypothyroid patients who were thyroid-resistant rather than thyroid-deficient undiagnosable.

Third, in proving that he could select candidates for treatment with a near 100% success rate he was able to run double-blind studies (again, anomalous that a chiropractor would do such a thing) that had absolutely overwhelming "p" values. (zero to six decimal places on only 12 crossovers)

Fourth, it is predicted that we should be able to formulate multiple daughter hypotheses from the original work, and sure enough, we are in a good position to say that in addition to fibromyalgia (FMS) being a phenotypic expression of thyroid hormone resistance, so too appear to be chronic fatigue syndrome (CFIDS), gulf war syndrome (GWS), electromagnetic field sensitivity (EMFS), multiple chemical sensitivity (MCS), PMS, and breast silicone implant rejection syndrome.

Note that Dr. Garrison is carefully treating extreme EMFS patients with cyclic megadoses of T3 with success. It is absolutely essential that any treatment be done under a knowledgeable physicians care. Interested persons may wish to contact one of Dr. Garrison's patients, Susan McDonald at .

Dr. Garrison is very busy at the present time (8/98) initiating a 100-patient Gulf War Syndrome research project (approved by the VA) , utilizing T3 to treat their FMS-like symptoms. Start-up of the research project awaits USA-duplication confirmation trials (for FDA approval) of a new biomarker, Hyaluronic Acid. discovered and confirmed in Israel last year for FMS [3]. HA serum levels were 10 times greater in FM patients compared to healthy controls.